Defensive growth characteristics and solid cash flow generation. Q3 2023 to confirm growth and margin recovery. Up to BUY (Sell) at 7.5x NTM EV/EBITDA.

05 Oct 2023
Reliable cash flow machine

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Reliable cash flow machine
- Published:
05 Oct 2023 -
Author:
ABGSC Healthcare Research | Sten Gustafsson -
Pages:
19 -
Defensive growth characteristics and solid cash flow generation. Q3 2023 to confirm growth and margin recovery. Up to BUY (Sell) at 7.5x NTM EV/EBITDA.